Evidence map›Paper›PMID 38187598›Full record

ArticlebioRxiv : the preprint server for biology2023

CD4

Joshua D Bromley, Sharie Keanne C Ganchua, Sarah K Nyquist, Pauline Maiello, Michael Chao, H Jacob Borish, Mark Rodgers, Jaime Tomko, Kara Kracinovsky, Douaa Mugahid and 12 more

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 1 country.

Joshua D BromleyRagon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
Sharie Keanne C GanchuaDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh PA USA.
Sarah K NyquistRagon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
Pauline MaielloDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh PA USA.
Michael ChaoRagon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
H Jacob BorishDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh PA USA.
Mark RodgersDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh PA USA.
Jaime TomkoDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh PA USA.
Kara KracinovskyDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh PA USA.
Douaa MugahidRagon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
Son NguyenRagon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
Dennis WangInstitute for Medical Engineering and Science (IMES), Massachusetts Institute of Technology, Cambridge, MA, USA.
Jacob M RosenbergRagon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
Edwin C KleinDivision of Laboratory Animal Research, University of Pittsburgh, Pittsburgh, PA, USA.
Hannah P GideonDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh PA USA.
Roisin Floyd-O'SullivanRagon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
Bonnie BergerComputer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA, USA.
Charles A ScangaDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh PA USA.
Philana Ling LinCenter for Vaccine Research, University of Pittsburgh, Pittsburgh PA USA.
Sarah M FortuneRagon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
Alex K ShalekRagon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
JoAnne L FlynnDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh PA USA.
University of Pittsburgh · USBroad Institute · USHarvard University · USMassachusetts Institute of Technology · US

Funding

IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)75N93019C00071 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI FORTUNE, SARAH · 2019 to 2025
$57.3M
Nonhuman Primate Reagent ResourceU24AI126683 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Diogo Magnani · 2016 to 2026
$20.1M
Resource CoreP40OD028116 · OD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Diogo Magnani · 2020 to 2026
$5.9M
Graduate Training in Computational and Systems BiologyT32GM087237 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BURGE, CHRISTOPHER B · 2009 to 2023
$4.6M
The Consequences of Reinfection with M. tuberculosisR01AI114674 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FLYNN, JOANNE L., FORTUNE, SARAH · 2015 to 2019
$3.4M
NIAID NIH HHS 75N93019C00071NIAID NIH HHS R01 AI114674NIAID NIH HHS U24 AI126683NIGMS NIH HHS T32 GM087237NIH HHS P40 OD028116
6 · The paper itself

Abstract

Immunological priming - either in the context of prior infection or vaccination - elicits protective responses against subsequent

Identifiers

PMID38187598
PMCPMC10769325
OpenAlexW4390081506

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.